Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway

In the central nervous system diseases, glioma is one of the most common malignancies around the world. Despite the recent improvements in therapies for glioma, the prognosis of some high‐risk glioma remains poor. In glioma, isoliquiritigenin (ISL) is reported to have antioxidative and antitumor act...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Aiqun, Jiang, Baohong, Song, Cailu, Zhong, Qizhi, Mo, Yufan, Yang, Ruiqin, Chen, Ciyu, Peng, Cheng, Peng, Fu, Tang, Hailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220153/
https://www.ncbi.nlm.nih.gov/pubmed/37250146
http://dx.doi.org/10.1002/mco2.282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220153/
https://www.ncbi.nlm.nih.gov/pubmed/37250146
http://dx.doi.org/10.1002/mco2.282

Ejemplares similares